Cargando…
Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019
BACKGROUND: It is known that coronavirus disease-2019 (COVID-19) pneumonia causes cytokine storm, and treatment modalities are being developed on inhibition of proinflammatory cytokines. We aimed to investigate the effects of anticytokine therapy on clinical improvement and the differences between a...
Autores principales: | Ozkan, Feyza, Sari, Süleyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983662/ https://www.ncbi.nlm.nih.gov/pubmed/36876207 http://dx.doi.org/10.5005/jp-journals-10071-24320 |
Ejemplares similares
-
Update on Anticytokine Treatment for Asthma
por: Gallelli, Luca, et al.
Publicado: (2013) -
Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets
por: Slessarev, Marat, et al.
Publicado: (2020) -
Viral Anticytokine Strategies
por: Alcami, Antonio
Publicado: (2016) -
Anticytokine therapy for periodontal diseases: Where are we now?
por: Waykole, Yogesh Prakash, et al.
Publicado: (2009) -
Anticytokine Autoantibodies and Fungal Infections
por: Kappagoda, Shanthi, et al.
Publicado: (2023)